NOTIZIE
COMUNICATI STAMPA
Impulse Dynamics Announces First International Implants of the Optimizer Smart Mini System in Italy
PRESS RELEASE MARLTON, N.J., JUNE 14, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a commercial-stage medical device company focused on delivering our CCMTM therapy to people with heart failure, announced that the first implants in Europe for the newly launched...
Late-breaking Results Show Efficacy for CCM in Patients With HFpEF
PRESS RELEASE  Investigators Report Positive Findings From Feasibility Study of CCM in Heart FailureWith Preserved Ejection Fraction at the European Society of Cardiology Heart Failure 2022 Congress MADRID and MARLTON, N.J., May 23, 2022 (GLOBE NEWSWIRE) — Impulse...
Impulse Dynamics Completes $101M Financing Round
PRESS RELEASE Financing To Support Commercial Acceleration of the Optimizer Smart Mini, Enrollment in the Landmark AIM HIGHer Clinical Trial, and Continued Development of a CCM-D Combination DeviceMARLTON, N.J., May 12, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a...
Impulse Dynamics Announces First Implants Of Optimizer Smart Mini
PRESS RELEASE Company Is Committed to Innovation for Patients Living With Heart Failure MARLTON, N.J., May 10, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), is announcing...
IMPULSE DYNAMICS LAUNCHES OPTIMIZER SMART MINI
PRESS RELEASESmaller, Smarter, Long-lasting Device Gives Patients a Reason To Believe There Is a Tomorrow MARLTON, N.J., April 29, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure...
IMPULSE DYNAMICS ANNOUNCES 7,000TH PATIENT TREATED WITH CCM® REINFORCING SIGNIFICANT CLINICAL EXPERIENCE
PRESS RELEASE CCM Therapy Addresses an Unmet Clinical Need and Offers Hope to Millions With Heart Failure MARLTON, N.J., April 26, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure...
IMPULSE DYNAMICS’ QUALITY MANAGEMENT SYSTEM RECEIVES CERTIFICATION UNDER EUROPEAN UNION MEDICAL DEVICE REGULATION
PRESS RELEASE Impulse Dynamics Is Now Among the First US-based Manufacturers of Active Implantable Devices To Receive Certification MARLTON, N.J., March 22, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a company dedicated to innovative treatments for chronic heart...
IMPULSE DYNAMICS ANNOUNCES FIRST PATIENT ENROLLED IN AIM HIGHer — IMPLANTABLE DEVICE TRIAL TO TREAT HEART FAILURE IN HIGHER EF POPULATION
PRESS RELEASE Trial Evaluates FDA-Designated BreakthroughTherapy for Patients Who Lack Treatment Options MARLTON, N.J., March 14, 2022 — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), today...
Impulse Dynamics Announces Chief Financial Officer Transition
NEWS Impulse Dynamics Announces Chief Financial Officer Transition Harriss Currie to Succeed Gerry Haines MARLTON, N.J., January 25, 2022 — Impulse Dynamics N.V., a company dedicated to improving the lives of people with heart failure, today announced the appointment...
Impulse Dynamics Receives Approval to Sell Optimizer CCM Devices in China
NEWS IMPULSE DYNAMICS RECEIVES APPROVAL TO SELL OPTIMIZER CCM DEVICES IN CHINA NMPA Clears the Way for Impulse Dynamics to Deliver Hope for Heart Failure Population MARLTON, N.J., February 22, 2021 — Impulse Dynamics, a company dedicated to improving the lives of...
© 2024 Impulse Dynamics       Condizioni di utilizzo | Protezione dei dati | Note legali | Privacy Policy